Planetary Technologies

Tandem PV, Inc. is a manufacturer of innovative photovoltaic cells that combine perovskite and silicon technologies to enhance solar panel efficiency. Founded in 2016 and based in Palo Alto, California, the company, previously known as Iris Photovoltaics, rebranded in February 2018. Tandem PV specializes in mechanically-stacked solar panels that integrate metal-halide perovskite semiconductors with traditional silicon cells. This integration aims to significantly improve the efficiency and economic viability of solar energy systems, providing clients with a substantial increase in the value and market potential of solar power while reducing installation costs. By leveraging advanced materials and technologies, Tandem PV seeks to contribute to the advancement of solar energy solutions.

Arzeda Corporation, founded in 2008 and based in Seattle, Washington, specializes in the development and commercialization of innovative enzymes and specialty chemical products. The company leverages advanced computational enzyme design technology to create designer proteins and enzymes tailored for diverse applications in polymers, pharmaceuticals, and industrial chemicals. By focusing on biocatalysis, Arzeda aims to provide clients with high-performance, cost-effective, and sustainable solutions that enhance their products. The company's expertise in synthetic biology positions it as a leader in the field, enabling the development of a robust portfolio that addresses the growing demand for advanced chemical products.

Parse Biosciences, based in Seattle, Washington, focuses on single-cell analysis and was incorporated in 2018. The company is dedicated to developing innovative technologies that enhance the understanding of cellular diversity and function at the single-cell level. By leveraging advanced methodologies, Parse Biosciences aims to provide researchers with powerful tools for exploring complex biological systems, ultimately advancing the fields of genomics and biomedical research.

Parse Biosciences, based in Seattle, Washington, focuses on single-cell analysis and was incorporated in 2018. The company is dedicated to developing innovative technologies that enhance the understanding of cellular diversity and function at the single-cell level. By leveraging advanced methodologies, Parse Biosciences aims to provide researchers with powerful tools for exploring complex biological systems, ultimately advancing the fields of genomics and biomedical research.

Lumen Bioscience, Inc. is a biotechnology company focused on developing therapeutic biologics for oral delivery. It utilizes Spirulina, a blue-green algae, as an industrial-scale production platform for high-value molecules. The company engages in various services, including synthetic biology, protein design, immunology, bioreactor engineering, and cell physiology, catering to the food, cosmetics, and healthcare industries. Founded in 2017 and based in Seattle, Washington, Lumen Bioscience is advancing the development of topically and mucosally delivered biologic drugs aimed at treating and preventing common diseases.

RoosterBio, Inc. is a biotechnology company specializing in the development of mesenchymal stem cells (MSCs) for the regenerative medicine sector. Founded in 2012 and headquartered in Frederick, Maryland, RoosterBio provides human bone marrow and adipose-derived MSCs designed for tissue engineers and cell therapists. These products aim to facilitate the creation of technologies, products, and devices that incorporate living cells. The company's offerings are intended to simplify and accelerate research in regenerative medicine by addressing common challenges in stem cell research and commercialization. RoosterBio has formed strategic alliances with organizations such as Pall Corporation and Tissue Regeneration Therapeutics Inc., further enhancing its capabilities in the field.

MicroByre, Inc. is a biotechnology company founded in 2017 and headquartered in Berkeley, California. The company focuses on developing genetically tractable strains from non-model micro-species, specializing in the domestication and genetic engineering of bacteria that are typically resistant to industrial applications. By utilizing a unique technology platform, MicroByre creates a reliable and generalizable domestication pipeline that supports fermentation processes. Its machine-learning platform analyzes a comprehensive dataset to identify bacteria that meet specific industrial functional criteria, facilitating precise genetic modifications. This approach provides clients with enhanced flexibility and yield while reducing the need for nutritional additives and improving contamination tolerance and phage resistance. Overall, MicroByre serves the biotechnology sector by addressing challenges in microbial utilization for industrial purposes.

Lumen Bioscience, Inc. is a biotechnology company focused on developing therapeutic biologics for oral delivery. It utilizes Spirulina, a blue-green algae, as an industrial-scale production platform for high-value molecules. The company engages in various services, including synthetic biology, protein design, immunology, bioreactor engineering, and cell physiology, catering to the food, cosmetics, and healthcare industries. Founded in 2017 and based in Seattle, Washington, Lumen Bioscience is advancing the development of topically and mucosally delivered biologic drugs aimed at treating and preventing common diseases.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

Riffyn, Inc. is a software company that provides a cloud-based platform designed for research and development in the life sciences, pharmaceutical, food, and chemical industries. Founded in 2014 and headquartered in Oakland, California, Riffyn's flagship product, Riffyn Nexus, enables users to visually design, measure, analyze, and collaborate on experiments. The software integrates diverse scientific data in real time, fostering enhanced data quality and facilitating reproducible discoveries. Riffyn's offerings include implementation, change management, and educational services, which support organizations in improving their research and development processes through advanced data analytics and machine learning capabilities. The company serves clients in the biopharmaceutical, industrial biotech, and materials sectors, both domestically and internationally.

Arzeda Corporation, founded in 2008 and based in Seattle, Washington, specializes in the development and commercialization of innovative enzymes and specialty chemical products. The company leverages advanced computational enzyme design technology to create designer proteins and enzymes tailored for diverse applications in polymers, pharmaceuticals, and industrial chemicals. By focusing on biocatalysis, Arzeda aims to provide clients with high-performance, cost-effective, and sustainable solutions that enhance their products. The company's expertise in synthetic biology positions it as a leader in the field, enabling the development of a robust portfolio that addresses the growing demand for advanced chemical products.

Riffyn, Inc. is a software company that provides a cloud-based platform designed for research and development in the life sciences, pharmaceutical, food, and chemical industries. Founded in 2014 and headquartered in Oakland, California, Riffyn's flagship product, Riffyn Nexus, enables users to visually design, measure, analyze, and collaborate on experiments. The software integrates diverse scientific data in real time, fostering enhanced data quality and facilitating reproducible discoveries. Riffyn's offerings include implementation, change management, and educational services, which support organizations in improving their research and development processes through advanced data analytics and machine learning capabilities. The company serves clients in the biopharmaceutical, industrial biotech, and materials sectors, both domestically and internationally.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

Riffyn, Inc. is a software company that provides a cloud-based platform designed for research and development in the life sciences, pharmaceutical, food, and chemical industries. Founded in 2014 and headquartered in Oakland, California, Riffyn's flagship product, Riffyn Nexus, enables users to visually design, measure, analyze, and collaborate on experiments. The software integrates diverse scientific data in real time, fostering enhanced data quality and facilitating reproducible discoveries. Riffyn's offerings include implementation, change management, and educational services, which support organizations in improving their research and development processes through advanced data analytics and machine learning capabilities. The company serves clients in the biopharmaceutical, industrial biotech, and materials sectors, both domestically and internationally.